SK Plasma Overview

  • Year Founded
  • 1970

Year Founded

  • Status
  • Private

  • Employees
  • 122

Employees

  • Latest Deal Type
  • IPO
  • (Postponed)

  • Financing Rounds
  • 6

  • Investments
  • 2

SK Plasma General Information

Description

Developer of plasma-derived medicine intended to promote human health and protect the environment. The company offers a plasma fractionation business and offers plasma-derived products that are essential medicines to treat diseases that can be directly linked to human life, such as congenital immunodeficiency diseases and hemophilia, enabling doctors to create social value to protect the health of human lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 310 Pangyo-ro
  • Bundang-gu
  • Seongnam-si, Gyeonggi-do 13494
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 310 Pangyo-ro
  • Bundang-gu
  • Seongnam-si, Gyeonggi-do 13494
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SK Plasma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SK Plasma‘s full profile, request access.

Request a free trial

SK Plasma Patents

SK Plasma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026216855-A1 Anti-ror1 antibody-drug conjugate and use thereof Pending 07-Apr-2025
WO-2023204377-A1 Method for purifying immunoglobulins Inactive 19-Apr-2022

SK Plasma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SK Plasma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SK Plasma‘s full profile, request access.

Request a free trial

SK Plasma Investments (2)

SK Plasma’s most recent deal was a Joint Venture with Proturk. The deal was made on 25-Nov-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Proturk 25-Nov-2025 Joint Venture Other Pharmaceuticals and Biotechnology
Joint Venture (SK Plasma/PT Infion) 08-Mar-2023 Joint Venture Biotechnology
To view SK Plasma’s complete investments history, request access »

SK Plasma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
SK Plasma Core Indonesia Indonesia

SK Plasma FAQs

  • When was SK Plasma founded?

    SK Plasma was founded in 1970.

  • Where is SK Plasma headquartered?

    SK Plasma is headquartered in Seongnam-si, South Korea.

  • What is the size of SK Plasma?

    SK Plasma has 122 total employees.

  • What industry is SK Plasma in?

    SK Plasma’s primary industry is Pharmaceuticals.

  • Is SK Plasma a private or public company?

    SK Plasma is a Private company.

  • What is the current valuation of SK Plasma?

    The current valuation of SK Plasma is .

  • What is SK Plasma’s current revenue?

    The current revenue for SK Plasma is .

  • How much funding has SK Plasma raised over time?

    SK Plasma has raised $281M.

  • Who are SK Plasma’s investors?

    Hahn & Company and SK Discovery have invested in SK Plasma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process